Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Ploessl

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Journal of Fluorine Chemistry|May 27, 2017
Fluorination at the 4 position alters the substrate behavior of L-glutamine and L-glutamate: Implications for positron emission tomography of neoplasiasThomas M Jeitner, Eva Kristoferson, Juan A Azcona, et al.
Molecular Pharmaceutics|March 21, 2023
[<sup>68</sup>Ga]Ga-HBED-CC-FAPI Derivatives with Improved Radiolabeling and Specific Tumor UptakeHaiyan Hong, Zhihao Zha, Ruiyue Zhao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2011
Preparation and characterization of L-[5-11C]-glutamine for metabolic imaging of tumorsWenchao Qu, Shunichi Oya, Brian P Lieberman, et al.
EJNMMI Radiopharmacy and Chemistry|October 16, 2024
First-in-human study of D6-[<sup>18</sup>F]FP-(+)-DTBZ, a novel VMAT2 tracer: whole-body biodistribution and brain PET comparison with [<sup>18</sup>F]FP-(+)-DTBZ (AV-133)Ruiyue Zhao, Jinhua Chen, Ting Ye, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 24, 2024
Comparison of novel PSMA-targeting [<sup>177</sup>Lu]Lu-P17-087 with its albumin binding derivative [<sup>177</sup>Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human studyLinlin Li, Jiarou Wang, Guochang Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 17, 2024
First-in-human study of dosimetry, safety and efficacy for [<sup>177</sup>Lu]Lu-P15-073: a novel bisphosphonate-based radioligand therapy (RLT) agent for bone metastasesRuiyue Zhao, Jie Lv, Mingzhao Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 11, 2024
First-in-human study of PSMA-targeting agent, [<sup>18</sup>F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patientsRuiyue Zhao, Miao Ke, Jie Lv, et al.
Science Translational Medicine|February 13, 2015
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivoSriram Venneti, Mark P Dunphy, Hanwen Zhang, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Journal of Fluorine Chemistry|May 27, 2017
Fluorination at the 4 position alters the substrate behavior of L-glutamine and L-glutamate: Implications for positron emission tomography of neoplasiasThomas M Jeitner, Eva Kristoferson, Juan A Azcona, et al.
Molecular Pharmaceutics|March 21, 2023
[<sup>68</sup>Ga]Ga-HBED-CC-FAPI Derivatives with Improved Radiolabeling and Specific Tumor UptakeHaiyan Hong, Zhihao Zha, Ruiyue Zhao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2011
Preparation and characterization of L-[5-11C]-glutamine for metabolic imaging of tumorsWenchao Qu, Shunichi Oya, Brian P Lieberman, et al.
EJNMMI Radiopharmacy and Chemistry|October 16, 2024
First-in-human study of D6-[<sup>18</sup>F]FP-(+)-DTBZ, a novel VMAT2 tracer: whole-body biodistribution and brain PET comparison with [<sup>18</sup>F]FP-(+)-DTBZ (AV-133)Ruiyue Zhao, Jinhua Chen, Ting Ye, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 24, 2024
Comparison of novel PSMA-targeting [<sup>177</sup>Lu]Lu-P17-087 with its albumin binding derivative [<sup>177</sup>Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human studyLinlin Li, Jiarou Wang, Guochang Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 17, 2024
First-in-human study of dosimetry, safety and efficacy for [<sup>177</sup>Lu]Lu-P15-073: a novel bisphosphonate-based radioligand therapy (RLT) agent for bone metastasesRuiyue Zhao, Jie Lv, Mingzhao Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 11, 2024
First-in-human study of PSMA-targeting agent, [<sup>18</sup>F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patientsRuiyue Zhao, Miao Ke, Jie Lv, et al.
Science Translational Medicine|February 13, 2015
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivoSriram Venneti, Mark P Dunphy, Hanwen Zhang, et al.
Pageof 6